In a continuing trend of policy change driven by the NIH, certain pandemic-focused language is being removed from health institute websites.

Lower nucleus accumbens volume independently predicts depressive symptoms and future anhedonia in patients with early relapsing-remitting MS.

Exposure to cognitive enrichment is associated with a slower rate of cognitive decline and lower risk for Alzheimer disease and dementia.

Certain progestin-only injectable contraceptives are associated with a significantly increased risk for surgically treated intracranial meningioma.

Higher consumption of caffeinated coffee and tea is associated with a reduced risk for dementia and improved cognitive function.

The ongoing measles outbreak across several US states has prompted an administration health official to advocate for the ...

The validated 6-variable IsCHEMiA score accurately identifies patients at high risk for developing epilepsy following an acute ischemic stroke.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma (R/R ...

Findings from the ASA International Stroke Conference show tenecteplase 4.5 to 24 hours after onset improves 90-day functional outcomes.

New AAN guidance addresses communicating brain death determinations to surrogates and managing objections to life support withdrawal.

Persistent post-stroke vertigo leads to poorer outcomes and reduced mobility, even in patients with high rehabilitation participation rates.

Treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I under review.